Zdrowie i gospodarka · 22/02/2019

FDA Releases Draft Guidance for Nicotine Replacement Therapy Drug Products

The Food and Drug Administration (FDA) has released a draft guidance document for the pharmaceutical industry, titled 'Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products.' This document aims to assist sponsors in the clinical development of nicotine replacement therapy (NRT) products, primarily for smoking cessation and related chronic conditions.